Tenon Medical Q2 revenue up 127% to $1.3M; net loss $4.1M; closes $4.2M offering

Tenon Medical, Inc.

Q2 revenue $1.3M (+127% YoY); gross profit $0.8M (64% margin vs 43% in Q2 2025).
Net loss $4.1M ($12.35/share) vs $2.8M ($12.76/share) in Q2 2025; cash $1.7M at June 30.
Closed $4.2M public offering July 1, net ~$3.6M; partial repayment of $5.2M convertible notes due Sept 11, 2026.
FDA 510(k) clearance for Catamaran SI Joint Fusion System; record July case volume after 98% training-event increase.
Effected 1-for-35 reverse stock split Aug 10; working to regain Nasdaq minimum bid price compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.